ORAMED PHARMACEUTICALS INC. Debt Securities, Available-for-sale, Amortized Cost
ORAMED PHARMACEUTICALS INC. (ORMP) had Debt Securities, Available-for-sale, Amortized Cost of $510.00 thousand as of 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2024-03-06
- 2023-06-30: Debt Securities, Available-for-sale, Amortized Cost $510.00K.
- 2023-03-31: Debt Securities, Available-for-sale, Amortized Cost $1.76M.
- 2022-12-31: Debt Securities, Available-for-sale, Amortized Cost $3.31M.
- 2022-09-30: Debt Securities, Available-for-sale, Amortized Cost $4.53M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost | Debt Securities, Available-for-sale, Amortized Cost as first filed |
|---|---|---|
| 2023-06-30 | $510.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $1.76M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $3.31M 10-K · filed 2024-03-06 | |
| 2022-09-30 | $4.53M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $6.48M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $3.31M 10-Q · filed 2023-05-11 | $7.92M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $10.42M 10-K · filed 2023-03-06 | |
| 2021-11-30 | $10.58M 10-Q · filed 2022-01-11 | |
| 2021-08-31 | $11.27M 10-QT · filed 2022-03-30 | |
| 2020-08-31 | $9.30M 10-K · filed 2021-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |